Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception Journal Article


Authors: Urai, Á; Váradi, A.; Szőcs, L.; Komjáti, B.; Le Rouzic, V.; Hunkele, A.; Pasternak, G. W.; Majumdar, S.; Hosztafi, S.
Article Title: Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception
Abstract: It was previously reported that 6β-aminomorphinan derivatives show high affinity for opiate receptors. Novel 6β-heteroarylamidomorphinanes were designed based on the MOR selective antagonist NAP. The 6β-aminomorphinanes were prepared by stereoselective Mitsunobu reaction and subsequently acylated with nicotinic acid and isonicotinic acid chloride hydrochlorides. The receptor binding and efficacy were determined in vitro and the analgesic activity was studied in vivo. The in vitro studies revealed moderate selectivity for the MOR. At least two compounds in this series exhibited a long-lasting analgesic response when administered subcutaneously and intracerebroventricularly. When the substances were given intracerebroventricularly to mice, they showed analgesic potency comparable to morphine. © The Royal Society of Chemistry.
Journal Title: MedChemComm
Volume: 8
Issue: 1
ISSN: 2040-2503
Publisher: Royal Society of Chemistry  
Date Published: 2017-01-01
Start Page: 152
End Page: 157
Language: English
DOI: 10.1039/c6md00450d
PROVIDER: scopus
PMCID: PMC5464418
PUBMED: 28603600
DOI/URL:
Notes: Article -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gavril W Pasternak
    414 Pasternak
  2. Amanda Joy Hunkele
    17 Hunkele